By Counterforce Health Team in Mycapssa (octreotide, oral) —

How to Get Mycapssa (Octreotide Oral) Covered by Humana in Pennsylvania: Complete Prior Authorization Guide

Quick Answer: Getting Mycapssa Covered by Humana in Pennsylvania

Mycapssa (oral octreotide) requires prior authorization from Humana Medicare Advantage plans in Pennsylvania. You'll need documented proof of acromegaly diagnosis, prior response to injectable somatostatin analogs (like Sandostatin LAR or Somatuline Depot), and an endocrinologist's prescription. If denied, Pennsylvania's new external review program has a 50% overturn rate. First step today: Contact your endocrinologist to gather IGF-1 lab results and injectable SSA treatment records, then submit the PA request through Humana's provider portal or call 1-800-281-6918.

Table of Contents

Humana Plan Types & Coverage Implications

Humana operates primarily Medicare Advantage plans in Pennsylvania, with some employer-sponsored options. Your plan type affects how Mycapssa coverage works:

Medicare Advantage (Part C): Most common Humana plan in PA. Mycapssa falls under Part D prescription drug benefits, requiring prior authorization as a specialty-tier medication.

Medicare Part D Only: If you have Original Medicare plus a standalone Humana Part D plan, the same PA requirements apply.

Network Requirements: You don't need referrals for endocrinologists in most Humana Medicare Advantage plans, but staying in-network reduces your costs significantly.

Mycapssa Formulary Status & Tiers

Coverage at a Glance

Requirement Details Where to Verify Source
Prior Authorization Required for all plans Humana formulary lookup Humana Drug Lists
Formulary Tier Tier 4-5 (specialty) Plan-specific formulary Provider Portal
Step Therapy Must try injectable SSAs first PA criteria documentation Humana Medical Policy
Quantity Limits May apply based on dosing Prescription details Contact Humana at 1-800-281-6918
Appeals Deadline 65 days from denial Denial notice Medicare Appeals

Alternative Agents: Humana typically prefers injectable somatostatin analogs like octreotide LAR (Sandostatin LAR) and lanreotide (Somatuline Depot) as first-line treatments before approving Mycapssa.

Prior Authorization Requirements

Medical Necessity Criteria

Humana requires documentation that you meet FDA-approved indications for Mycapssa:

Diagnosis Requirements:

  • Confirmed acromegaly (ICD-10 code E22.0)
  • IGF-1 levels above age-adjusted normal ranges (specific values required)
  • Growth hormone suppression test results if available

Step Therapy Documentation:

  • Prior treatment with injectable octreotide LAR or lanreotide
  • Evidence of biochemical response (normalized or reduced IGF-1 levels)
  • Duration of injectable therapy (typically 3-6 months minimum)

Switch Rationale:

  • Patient preference for oral therapy
  • Injection site reactions or access difficulties
  • Maintained biochemical control expected

Clinician Corner: Medical Necessity Letter Checklist

For Prescribers: Your medical necessity letter should include:Patient's acromegaly diagnosis with specific lab values and datesComplete history of injectable SSA therapy (drug names, doses, duration)Pre- and post-treatment IGF-1 levels showing responseClinical rationale for switching to oral therapyMonitoring plan for continued treatmentReference to FDA prescribing information supporting use in SSA responders

Step-by-Step: Fastest Path to Approval

1. Gather Required Documentation (Patient/Clinic)

What you need:

  • IGF-1 lab results from before and during injectable SSA therapy
  • Pharmacy records or clinic notes documenting octreotide LAR or lanreotide use
  • Current acromegaly symptoms and functional status
  • Insurance card and member ID

Timeline: 1-2 business days to collect records

2. Endocrinologist Completes PA Request (Prescriber)

Submission method: Humana Provider Portal or fax to number on PA form Required elements:

  • Completed prior authorization form
  • Medical necessity letter with clinical rationale
  • Supporting lab results and treatment history
  • Prescription for specific Mycapssa dosing

Timeline: 72 hours for standard review, 24 hours if expedited

3. Specialty Pharmacy Coordination (Patient)

Contact: CenterWell Specialty Pharmacy at 1-800-486-2668 Setup requirements:

  • Insurance verification
  • Prescription transfer from retail pharmacy
  • Patient education on administration timing
  • Delivery scheduling

Timeline: 2-3 business days after PA approval

4. Monitor Approval Status (Patient/Clinic)

Check via: Humana member portal or provider system Follow up: If no response within standard timeframe, call member services Documentation: Save all correspondence for potential appeals

Specialty Pharmacy Requirements

Mycapssa must be dispensed through Humana's preferred specialty pharmacy network, primarily CenterWell Specialty Pharmacy. This isn't optional—retail pharmacies typically cannot fill this prescription under Medicare Part D rules.

Setup Process:

  1. CenterWell will contact you after PA approval
  2. Complete patient intake and insurance verification
  3. Schedule delivery (requires signature)
  4. Receive administration counseling

Key Requirements:

  • Take on empty stomach, 1 hour before or 2 hours after food
  • Swallow whole—do not crush or chew
  • Store at room temperature
  • Report side effects to prescriber and pharmacy
From our advocates: We've seen patients successfully transition from injectable to oral octreotide by emphasizing the maintained biochemical control in their medical necessity letters. One key factor: including specific IGF-1 values with reference ranges, not just "elevated" or "improved" descriptions, which can lead to denials.

Cost-Share Breakdown

Typical Medicare Part D Coverage (2025):

  • Tier 5 Specialty: 33% coinsurance until reaching out-of-pocket maximum
  • Out-of-pocket maximum: $2,000 for 2025
  • Coverage gap: 25% of drug cost in the "donut hole"

Estimated Monthly Costs:

  • Before deductible: ~$2,200-2,400 per month (33% of ~$6,685 cash price)
  • After out-of-pocket max: Minimal copay

Financial Assistance Options:

  • Medicare Extra Help: Income-based assistance reducing costs to ~$11.20/month
  • Manufacturer support: Check Chiesi Global Rare Diseases for patient assistance programs
  • State pharmaceutical assistance: Pennsylvania PACE/PACENET for eligible seniors

This is educational information only—actual costs vary by plan and should be verified with Humana.

Common Denial Reasons & Solutions

Denial Reason How to Overturn Required Documentation
No prior SSA trial documented Submit pharmacy records or clinic notes Humana Appeals Process
Insufficient response evidence Provide pre/post IGF-1 labs with dates Lab results with reference ranges
Off-label use Medical necessity letter with literature FDA labeling and clinical guidelines
Non-formulary status Request formulary exception Comparative effectiveness data
Quantity limit exceeded Clinical justification for higher dose Endocrinologist dosing rationale

Most Effective Appeal Strategy: Include specific lab values, exact dates of prior treatments, and clear clinical rationale from an endocrinologist. Generic statements like "patient failed prior therapy" are insufficient.

Appeals Process in Pennsylvania

Pennsylvania offers one of the strongest patient appeal systems in the country. If Humana denies your Mycapssa request, you have multiple levels of recourse:

Level 1: Humana Internal Appeal (Redetermination)

Timeline: 65 days from denial notice to file Decision timeframe: 7 days standard, 72 hours expedited How to file:

  • Online via Humana member portal
  • Mail using "Request for Redetermination" form to Humana Health Plans, P.O. Box 14165, Lexington, KY 40512-4165
  • Phone: 1-800-451-4651 (TTY: 711)

Level 2: Independent Review Entity (IRE)

Timeline: 60 days from Humana's denial to file Decision timeframe: 7-14 days standard, 72 hours expedited Process: Automatic referral to Medicare-contracted independent reviewers

Level 3: Pennsylvania External Review (If Still Denied)

Pennsylvania's Advantage: New state-run external review program with 50% overturn rate Timeline: 4 months from final internal denial How to file: Online at Pennsylvania Insurance Department or mail/fax using PID forms Decision timeframe: 45 days standard, 72 hours expedited

Key Success Factors:

  • Submit additional clinical evidence within 15 days of IRO assignment
  • Include peer-reviewed literature supporting oral octreotide use
  • Emphasize maintained disease control and quality of life benefits

When to Escalate to State Regulators

Contact the Pennsylvania Insurance Department's Office of Consumer Services if:

  • Humana fails to meet appeal deadlines
  • You encounter procedural barriers
  • You need help navigating the external review process

Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals by analyzing denial letters, plan policies, and clinical notes to draft point-by-point rebuttals aligned with payer requirements.

FAQ: Mycapssa Coverage Questions

How long does Humana prior authorization take in Pennsylvania? Standard PA decisions take 72 hours; expedited requests (when health is at risk) are decided within 24 hours. You can request expedited review if delays could harm your health.

What if Mycapssa is non-formulary on my plan? Request a formulary exception through the same PA process. You'll need stronger evidence showing why preferred alternatives (injectable SSAs) are inappropriate or ineffective for you.

Can I request an expedited appeal? Yes, if waiting for standard appeal timelines could seriously harm your health. Your endocrinologist can support this request with clinical documentation.

Does step therapy apply if I tried injectables outside Pennsylvania? Yes, treatment history from any state counts. Provide documentation of your injectable SSA trial and response, regardless of where it occurred.

What happens if I'm already taking Mycapssa and Humana denies continuation? File an expedited appeal immediately, as stopping treatment could cause symptom recurrence. Humana may provide temporary coverage during the appeal process.

Can my endocrinologist request a peer-to-peer review? Yes, peer-to-peer reviews with Humana's medical director can resolve denials quickly. Your prescriber should request this through the provider portal or by calling the number on the denial letter.

About Counterforce Health

Counterforce Health helps patients, clinicians, and specialty pharmacies navigate complex prior authorization and appeals processes. Our platform analyzes denial letters and plan policies to create targeted, evidence-backed appeals that speak directly to payer requirements. By pulling the right clinical evidence—from FDA labeling to peer-reviewed studies—and aligning it with specific plan criteria, we help turn denials into approvals. Learn more about our services at www.counterforcehealth.org.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies and appeal procedures may change. Always verify current requirements with Humana directly and consult your healthcare provider for medical decisions. For personalized assistance with insurance appeals, contact the Pennsylvania Insurance Department's Office of Consumer Services or consider working with coverage advocates like Counterforce Health.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.